|
BWXT Medical and other licensees will participate in an annual public meeting held by Canada’s nuclear regulator, the Canadian Nuclear Safety Commission (CNSC).
Each year, BWXT Medical submits an Annual Compliance Report (ACR) to the CNSC with the purpose of demonstrating that BWXT Medical has successfully met the requirements of the Nuclear Safety and Control Act and its Class IB nuclear substance processing facility licence.
At the meeting, CNSC Staff will present the annual Regulatory Oversight Report for 2024 for BWXT Medical and other licensees. The meeting will be held the week of March 23, 2026.
More information can be found on the CNSC's website here.
|